Clinical Trials Directory

Trials / Completed

CompletedNCT01087385

Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease

Troponin T as Risk Stratification Tool in Patients With Peripheral Arterial Occlusive Disease

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
University Heart Center Freiburg - Bad Krozingen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study hypothesis: elevated Troponin T is a marker of increased mortality in patients with peripheral arterial occlusive disease (PAOD).

Detailed description

Troponin T and I are established risk markers in patients with acute coronary syndrome. Only recently, troponin I was found to be elevated in patients with acute critical limb ischaemia. In another study, troponin I was associated with a higher mortality in patients with chronic critical limb ischaemia followed over two years. In a longitudinal study design we intend to follow all patients that were treated for symptomatic PAOD (Fontaine stages II-IV) from 01/2007 to 12/2007 in our department of angiology. Main outcome parameters are death and the occurrence of major vascular events and revascularization procedures during follow-up.

Conditions

Timeline

Start date
2010-03-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-03-16
Last updated
2015-04-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01087385. Inclusion in this directory is not an endorsement.

Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease (NCT01087385) · Clinical Trials Directory